Vogelsang G D, Zemlan F P, Dean G E
Alzheimer's Research Center, University of Cincinnati College of Medicine, Ohio 45267-0524.
J Neurochem. 1990 Jan;54(1):148-55. doi: 10.1111/j.1471-4159.1990.tb13295.x.
The purpose of the present study was to develop a purification and solubilization method, compatible with current amino acid sequencing techniques, for paired helical filaments (PHFs) derived from patients with Alzheimer's disease. We have developed a mild procedure that subjects conventionally isolated PHFs to Tris/borate/sodium dodecyl sulfate/2-mercaptoethanol electrophoresis and results in the separation of the relatively insoluble PHF structures from both copurifying contaminating proteins and solubilized PHF-associated proteins. At the end of 4.5 h of electrophoresis, the purified insoluble fraction had an amino acid composition that was invariant during subsequent electrophoresis. Electron microscopy revealed an intact PHF structure before and after electrophoresis but no evidence of any other structures in the insoluble fraction, a result consistent with the removal of PHF-associated proteins from the filament structure. Isolated insoluble filament structures displayed an enhanced immunoreactivity with antibodies raised against purified PHFs in other laboratories, when compared with the fraction not subjected to electrophoresis in enzyme-linked immunosorbent assays. Solubilization of the relatively insoluble PHFs was accomplished by extending the time of electrophoresis beyond the 4.5 h required for purification. Additional electrophoresis for 34.5 h solubilized 88% of the purified, relatively insoluble PHFs. This resulted in the identification of four major protein bands between Mr values of approximately 50,000 and 70,000 on sodium dodecyl sulfate-polyacrylamide electrophoresis gel analysis, with a predominant band with an Mr of approximately 66,000. A slow fragmentation of the PHF ultrastructure occurred during this time, as judged by electron microscopy. This purification technique will permit the isolation of consistently reproducible protein fragments from solubilized PHFs, which may be used for subsequent sequence analysis.
本研究的目的是开发一种与当前氨基酸测序技术兼容的纯化和增溶方法,用于从阿尔茨海默病患者中提取的成对螺旋丝(PHF)。我们开发了一种温和的方法,将传统分离的PHF进行Tris/硼酸盐/十二烷基硫酸钠/2-巯基乙醇电泳,从而将相对不溶性的PHF结构与共纯化的污染蛋白和增溶的PHF相关蛋白分离。在电泳4.5小时结束时,纯化的不溶性部分的氨基酸组成在随后的电泳过程中保持不变。电子显微镜显示,电泳前后PHF结构完整,但在不溶性部分未发现任何其他结构的证据,这一结果与从丝状结构中去除PHF相关蛋白一致。在酶联免疫吸附试验中,与未进行电泳的部分相比,分离出的不溶性丝状结构对其他实验室针对纯化的PHF产生的抗体表现出增强的免疫反应性。通过将电泳时间延长至纯化所需的4.5小时以上,实现了相对不溶性PHF的增溶。额外进行34.5小时的电泳可使88%的纯化相对不溶性PHF增溶。这导致在十二烷基硫酸钠-聚丙烯酰胺电泳凝胶分析中,在Mr值约为50,000至70,000之间鉴定出四条主要蛋白带,其中一条主要带的Mr约为66,000。根据电子显微镜判断,在此期间PHF超微结构发生了缓慢的断裂。这种纯化技术将允许从增溶的PHF中分离出可一致重现的蛋白片段,这些片段可用于后续的序列分析。